Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    WS07 - LATAM Workshop

    • 15:00 - 16:30
    • 8/06/2022
    • Location: Lehar 2
    • Not for CME Credit
    • Type: Workshop
    • Track: N/A
    • +

      WS07.06 - Real-world Evidence of Durvalumab for Stage III NSCLC: Survival Outcomes and Patterns of Care Post-progression

      15:32 - 15:42  |  Presenter: Pedro Aguiar Jr

      • Abstract

      Loading...

  • +

    IBS03 - Real World Discussion about Testing in Low Income Countries (Ticketed Session) (In-person Access Only)

    • 07:30 - 08:15
    • 8/07/2022
    • Location: Hall C7
    • IASLC CME Accredited
    • Type: Interactive Breakfast Session
    • Track: Global Health, Health Services Research, and Health Economics
    • +

      IBS03.01 - Real World Discussion about Testing in Low Income Countries

      07:30 - 07:45  |  Presenter: Rodrigo Dientsmann

      • Abstract

      Loading...

  • +

    EP04.01 - Global Health, Health Services Research, and Health Economics - Cost Issues

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Global Health, Health Services Research, and Health Economics - Cost Issues
    • +

      EP04.01-022 - Real-world Evidence of Durvalumab for Stage III NSCLC: Survival Outcomes and Patterns of Care Post-progression

      Presenter: Pedro Aguiar Jr

      • Abstract

      Loading...

  • +

    EP07.01 - Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical
    • +

      EP07.01-022 - Analysis of Second Surgery for Recurrence in Malignant Pleural Mesothelioma (MPM) Patients (P)

      Presenter: Susana Cedres

      • Abstract

      Loading...

    • +

      EP07.01-023 - Family History of Cancer in a Series of Malignant Pleural Mesothelioma (MPM) Patients (P)

      Presenter: Susana Cedres

      • Abstract

      Loading...

  • +

    EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      EP08.02-056 - Coexisting MET Exon 14 Skipping Mutation and MET Amplification in a Patient with Complete Response to MET Inhibitors

      Presenter: Flávia Amaral Duarte

      • Abstract

      Loading...